Press release
Carcinoembryonic Antigen (CEA) Market Size, Share, Industry, Forecast and outlook (2043-2031)
DataM Intelligence
The latest report on the Global Carcinoembryonic Antigen (CEA) Market projects a significant growth trajectory, with an expected Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period from 2024 to 2031. The surge is primarily attributed to the escalating demand witnessed from hospitals and clinics worldwide.
Carcinoembryonic antigen (CEA) serves as a crucial glycoprotein typically present in the embryonic endodermal epithelium. Notably, the CEA blood level can surge in certain cancerous and non-cancerous conditions, particularly in cancers of the large intestine such as colon and rectal cancer.
The comprehensive analysis provided in the Carcinoembryonic Antigen (CEA) Market study encompasses both quantitative and qualitative data, offering insights into market dynamics. Segmentation by Automated Health Assessment and Monitoring, type, application, and gender facilitates a detailed examination of the global market. Additionally, the report encompasses market sizing, growth projections, prevailing trends, and opportunities, extending up to 2029 across key countries including the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and other regions.
Driving Factors:
The global surge in cancer incidences is a primary driver propelling the Carcinoembryonic Antigen (CEA) market growth. According to the World Health Organization, cancer remains one of the leading causes of mortality worldwide, with an estimated 10 million deaths recorded in 2020 alone. With approximately 1 in 6 deaths attributed to cancer globally, the rising number of cases, particularly in low- and middle-income countries, underscores the urgent need for advanced diagnostic solutions. Factors such as increasing life expectancy and lifestyle changes contribute to the exponential rise in cancer diagnoses, further augmenting market growth.
Challenges:
Despite the market's promising outlook, challenges persist, notably in the form of inadequate awareness and suboptimal early detection approaches. The efficacy of cancer detection at the initial stage remains a concern, coupled with a lack of widespread awareness, hindering the full potential of the Carcinoembryonic Antigen (CEA) market.
Insights into the Industry:
The forthcoming global Carcinoembryonic Antigen (CEA) market report offers a comprehensive industry analysis, delving into factors such as Porter's Five Forces, innovations, new product launches, pricing analysis, and pipeline assessment.
Market Segmentation Analysis:
The gastrointestinal cancer application segment is anticipated to maintain dominance throughout the forecast period (2023-2030), with colorectal cancer being a significant contributor to market growth. Gastrointestinal cancers, including colorectal, pancreatic, liver, stomach, and esophageal cancers, are among the most prevalent worldwide, driving demand for minimally invasive diagnostic methods.
Geographical Landscape:
North America emerges as the frontrunner in the global Carcinoembryonic Antigen (CEA) market, boasting the largest market share in 2021. The region's dominance is fueled by increasing cancer incidence rates, heightened awareness regarding early cancer detection, and advanced healthcare infrastructure. Notably, the United States witnesses a significant surge in cancer cases, further solidifying North America's leadership position.
Competitive Landscape:
The Carcinoembryonic Antigen (CEA) market exhibits a competitive landscape characterized by major players striving to capture market share. Leading companies such as Quest Diagnostics, F. Hoffman LA Roche, GenWay Biotech Inc., Abbott Laboratories, and others engage in various growth strategies including product launches, mergers & acquisitions, partnerships, and collaborations to bolster market presence.
Related Reports:
Neglected tropical disease treatment market : https://datamintelligence.com/research-report/neglected-tropical-disease-treatment-market
Brachytherap market : https://datamintelligence.com/research-report/brachytherap-market
Motion sickness treatment market: https://datamintelligence.com/research-report/motion-sickness-treatment-market
Hospital infection therapeutics market: https://datamintelligence.com/research-report/hospital-infection-therapeutics-market
Cancer cachexia market : https://datamintelligence.com/research-report/cancer-cachexia-market
Diffuse large b-cell lymphoma therapeutics market: https://datamintelligence.com/research-report/diffuse-large-b-cell-lymphoma-therapeutics-market
Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carcinoembryonic Antigen (CEA) Market Size, Share, Industry, Forecast and outlook (2043-2031) here
News-ID: 3447714 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Skin Cancer Drugs Market Set to Surge: Innovative Therapies and Ri …
Market Overview:
The Skin Cancer Drugs Market is estimated to reach at a CAGR of 10.2% during the forecast period (2024-2031).
The Skin Cancer Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…
United States Aircraft Battery Charger Market is expected to reach US$ 1032.9 Mi …
Market Size and Forecast:
The Global Aircraft Battery Charger Market Size reached US$ 570.5 million in 2022 and is expected to reach US$ 1032.9 million by 2030, growing with a CAGR of 7.9% during the forecast period 2024-2031.
The Aircraft Battery Charger Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
United States Cloud-based Printing Market is expected to reach US$ 3.96 billion …
Market Size and Forecast:
The Cloud-based Printing Market Size reached US$1.52 billion in 2024 and is expected to reach US$3.96 billion by 2032, growing with a CAGR of 12.71% during the forecast period 2025-2032.
The Cloud-based Printing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…
United States Beauty Devices for At-Home Laser Treatments Market is expected to …
Market Size and Forecast:
The Global Beauty Devices for At-Home Laser Treatments Market Size reached US$537.1 million in 2024 and is expected to reach US$1,302.5 million by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033.
The Beauty Devices for At-Home Laser Treatments Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM…
More Releases for CEA
CEA ELISA Kits Market Outlook and Future Projections for 2030
The cea elisa kits market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion.
Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain…
Carcinoembryonic Antigen (CEA) Market Investment Research Report 2017 – 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not…
Carcinoembryonic Antigen (CEA) Market foreseen to grow exponentially over 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not…
Carcinoembryonic Antigen (CEA) Market to hit $2.7bn by 2023
Carcinoembryonic Antigen (CEA) Market size is driven by increasing incidence rate for cancer disease especially colorectal cancer is one of the important factor contributing to the growth. Global Carcinoembryonic Antigen Market is set to register profitable growth in the near future and surpass USD 2.8 billion by 2023.
This growth is attributed to factors including consistent technology advancements, development of novel biomarkers and growing prevalence of cancer. Global Market Insights,…
CEA Antibodies Market Outlook And Research Survey To 2023
CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in…
